Zacks Investment Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,168	Closed	-$308K	–	688
2023 Q2	$308K	Sell	11,168 -693	-6%	-$19.1K	﹤0.01%	525
2023 Q1	$273K	Buy	+11,861	New	+$273K	﹤0.01%	539